NASDAQ:CELH - Celsius Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $4.15 +0.02 (+0.48 %) (As of 05/26/2019 01:08 PM ET)Previous Close$4.15Today's Range$4.0301 - $4.1952-Week Range$3.05 - $5.07Volume14,206 shsAverage Volume73,672 shsMarket Capitalization$237.83 millionP/E RatioN/ADividend YieldN/ABeta0.82 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Celsius Holdings, Inc. develops, markets, distributes, and sells functional calorie-burning fitness beverages in the United States and internationally. The company offers its beverages in various flavors, including carbonated orange, wild berry, cola, grape, kiwi-guava, and watermelon; and non-carbonated green tea raspberry/acai, green tea/peach mango, pineapple coconut, watermelon berry, and strawberries and cream, as well as sparkling grapefruit, cucumber lime, and orange pomegranate under the Celsius name. It also provides Celsius Heat, a dietary supplement in carbonated flavors, such as apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragonfruit, and tangerine grapefruit. The company distributes its products through direct-store delivery distributors, as well as directly to retailers across various retail segments comprising supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce Websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is based in Boca Raton, Florida. Receive CELH News and Ratings via Email Sign-up to receive the latest news and ratings for CELH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Bottled & canned soft drinks Sub-IndustryN/A SectorConsumer Staples Current SymbolNASDAQ:CELH Previous Symbol CUSIPN/A CIK1341766 Webhttp://www.ampliphibio.com/ Phone561-276-2239Debt Debt-to-Equity Ratio0.37 Current Ratio3.53 Quick Ratio2.07Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$52.60 million Price / Sales4.52 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book9.43Profitability EPS (Most Recent Fiscal Year)($0.23) Net Income$-11,210,000.00 Net Margins5.97% Return on Equity-59.91% Return on Assets-27.49%Miscellaneous Employees50 Outstanding Shares57,308,000Market Cap$237.83 million Next Earnings Date8/8/2019 (Estimated) OptionableNot Optionable Celsius (NASDAQ:CELH) Frequently Asked Questions What is Celsius' stock symbol? Celsius trades on the NASDAQ under the ticker symbol "CELH." How were Celsius' earnings last quarter? Celsius Holdings, Inc. (NASDAQ:CELH) released its quarterly earnings data on Thursday, May, 9th. The company reported ($0.01) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.02. The company had revenue of $14.49 million for the quarter, compared to the consensus estimate of $14.26 million. Celsius had a negative return on equity of 59.91% and a net margin of 5.97%. View Celsius' Earnings History. When is Celsius' next earnings date? Celsius is scheduled to release their next quarterly earnings announcement on Thursday, August 8th 2019. View Earnings Estimates for Celsius. What price target have analysts set for CELH? 2 brokerages have issued 12-month price objectives for Celsius' stock. Their predictions range from $7.00 to $8.00. On average, they anticipate Celsius' stock price to reach $7.50 in the next twelve months. This suggests a possible upside of 80.7% from the stock's current price. View Analyst Price Targets for Celsius. What is the consensus analysts' recommendation for Celsius? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celsius in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Celsius. What are Wall Street analysts saying about Celsius stock? Here are some recent quotes from research analysts about Celsius stock: 1. Maxim Group analysts commented, "Market open, CELH reported better-than-expected 4Q18 results, including domestic revenue above our estimate. GAAP loss per share was narrower-than-expected as CELH scaled back its China investment ahead of its transition to a licensing strategy. We are raising topline estimates on the revenue beat, but reducing EPS estimates on higher expected marketing and promotional investments." (3/14/2019) 2. According to Zacks Investment Research, "Celsius Holdings, Inc. specializes in commercializing healthier, nutritional functional foods, beverages and dietary supplements. Celsius Holdings, Inc. markets Celsius®, the calorie burner, through its wholly-owned operating subsidiary, Celsius, Inc. The Company sells its products through grocery, drug, convenience, club and mass, and health and fitness channels. The Company's products are produced in Mooresville, North Carolina, and Monroe, Wisconsin. Celsius, Inc. is dedicated to providing healthier, everyday refreshment through science and innovation. The Company serves customers in the United States and internationally. Celsius Holdings, Inc. is based in Delray Beach, Florida. " (2/5/2019) Has Celsius been receiving favorable news coverage? Media coverage about CELH stock has been trending negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Celsius earned a daily sentiment score of -2.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an effect on the company's share price in the next several days. Who are some of Celsius' key competitors? Some companies that are related to Celsius include Fomento Economico Mexicano SAB (FMX), Monster Beverage (MNST), Coca-Cola European Partners (CCEP), Coca-Cola FEMSA (KOF), COCA-COLA HBC A/ADR (CCHGY), BRITVIC PLC/S (BTVCY), Embotelladora Andina SA ADR Series B (AKO.B), Coca-Cola Consolidated (COKE), Embotelladora Andina SA ADR Series A (AKO.A), National Beverage (FIZZ), Cott (COT), Reeds (REED), Golfgear International (MCHA) and Leading Brands (LBIX). What other stocks do shareholders of Celsius own? Based on aggregate information from My MarketBeat watchlists, some companies that other Celsius investors own include New Age Beverages (NBEV), AVEO Pharmaceuticals (AVEO), Novavax (NVAX), Viewray (VRAY), Alibaba Group (BABA), UQM Technologies (UQM), Allena Pharmaceuticals (ALNA), ArQule (ARQL), Abraxas Petroleum (AXAS) and Baidu (BIDU). Who are Celsius' key executives? Celsius' management team includes the folowing people: Mr. John Fieldly, CEO & Director (Age 39)Mr. Edwin F. Negron-Carballo, Chief Financial Officer (Age 57)Ms. Sandy Telsaint, VP of OperationsMr. Matt Kahn, Exec. VP of MarketingMr. Jon McKillop, Sr. VP of Sales for North America Who are Celsius' major shareholders? Celsius' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Arcus Capital Partners LLC (37.31%), BlackRock Inc. (2.06%), Granite Investment Partners LLC (0.52%), Anchor Capital Advisors LLC (0.42%), Charles Schwab Investment Management Inc. (0.10%) and Raymond James Financial Services Advisors Inc. (0.06%). View Institutional Ownership Trends for Celsius. Which institutional investors are selling Celsius stock? CELH stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley. View Insider Buying and Selling for Celsius. Which institutional investors are buying Celsius stock? CELH stock was purchased by a variety of institutional investors in the last quarter, including Arcus Capital Partners LLC, Granite Investment Partners LLC, Anchor Capital Advisors LLC, BlackRock Inc., Raymond James Financial Services Advisors Inc., SG Americas Securities LLC, Virtu Financial LLC and Renaissance Technologies LLC. View Insider Buying and Selling for Celsius. How do I buy shares of Celsius? Shares of CELH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Celsius' stock price today? One share of CELH stock can currently be purchased for approximately $4.15. How big of a company is Celsius? Celsius has a market capitalization of $237.83 million and generates $52.60 million in revenue each year. The company earns $-11,210,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis. Celsius employs 50 workers across the globe. What is Celsius' official website? The official website for Celsius is http://www.ampliphibio.com/. How can I contact Celsius? Celsius' mailing address is 2424 N. FEDERAL HIGHWAY SUITE 208, BOCA RATON FL, 33431. The company can be reached via phone at 561-276-2239 or via email at [email protected] MarketBeat Community Rating for Celsius (NASDAQ CELH)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 126 (Vote Outperform)Underperform Votes: 133 (Vote Underperform)Total Votes: 259MarketBeat's community ratings are surveys of what our community members think about Celsius and other stocks. Vote "Outperform" if you believe CELH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CELH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/26/2019 by MarketBeat.com StaffFeatured Article: What is an SEC Filing? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.